Nivolumab is a recently approved medication for the treatment of unresectable malignant melanoma. Many immune-related adverse events (irAEs) associated with nivolumab have been reported. such as pneumonitis. hepatitis. https://www.roneverhart.com/Samsung-PM883-MZ7LH3T8HMLT-3-84TB-SATA-6Gb-s-2-5-AES-256-bit-Manufacturer-Recertified-SSD/